Which imaging modality best assesses diffuse axonal injury in the subacute phase?

Which imaging modality best assesses diffuse axonal injury in the subacute phase?

• A. MRI with SWI/DTI
• B. CT
• C. Ultrasound
• D. PET

Answer: (A)

Diffuse axonal injury is often invisible on routine CT scans because it involves microscopic axonal disruption and microhemorrhages in white matter tracts. In the subacute phase, the most informative imaging combines structural detail with sensitivity to tiny blood products and white matter integrity. MRI excels here, and two specific sequences are particularly powerful: SWI, which highlights even very small microhemorrhages that accompany DAI, especially in regions like the corpus callosum and deep white matter; and diffusion tensor imaging (DTI), which measures the direction and rate of water diffusion along white matter fibers. DTI provides a quantitative look at tract integrity; reduced fractional anisotropy indicates axonal injury even when conventional MRI appears nearly normal. In contrast, CT misses many DAI lesions, ultrasound cannot adequately evaluate intracranial parenchyma, and PET focuses on metabolic activity rather than direct structural axonal injury. So, using MRI with SWI to detect microbleeds and DTI to assess white matter tract disruption offers the most comprehensive assessment of diffuse axonal injury in the subacute phase.

Diffuse axonal injury is often invisible on routine CT scans because it involves microscopic axonal disruption and microhemorrhages in white matter tracts. In the subacute phase, the most informative imaging combines structural detail with sensitivity to tiny blood products and white matter integrity. MRI excels here, and two specific sequences are particularly powerful: SWI, which highlights even very small microhemorrhages that accompany DAI, especially in regions like the corpus callosum and deep white matter; and diffusion tensor imaging (DTI), which measures the direction and rate of water diffusion along white matter fibers. DTI provides a quantitative look at tract integrity; reduced fractional anisotropy indicates axonal injury even when conventional MRI appears nearly normal.

In contrast, CT misses many DAI lesions, ultrasound cannot adequately evaluate intracranial parenchyma, and PET focuses on metabolic activity rather than direct structural axonal injury. So, using MRI with SWI to detect microbleeds and DTI to assess white matter tract disruption offers the most comprehensive assessment of diffuse axonal injury in the subacute phase.